Literature DB >> 26542730

Late Diagnosis of HIV Infection in Metropolitan Areas of the United States and Puerto Rico.

H Irene Hall1, Tian Tang2, Lorena Espinoza3.   

Abstract

The majority of persons infected with HIV live in large metropolitan areas and many such areas have implemented intensified HIV testing programs. A national indicator of HIV testing outcomes is late diagnosis of HIV infection (stage 3, AIDS). Based on National HIV Surveillance System data, 23.3 % of persons with HIV diagnosed in 2012 had a late diagnosis in large MSAs, 26.3 % in smaller MSAs, and 29.6 % in non-metropolitan areas. In the 105 large MSAs, the percentage diagnosed late ranged from 13.2 to 47.4 %. During 2003-2012, the percentage diagnosed late decreased in large MSAs (32.2-23.3 %), with significant decreases in 41 of 105 MSAs overall and among men who have sex with men. Sustained testing efforts may help to continue the decreasing trend in late-stage HIV diagnosis and provide opportunities for early care and treatment and potential reduction in HIV transmission.

Entities:  

Keywords:  AIDS; CD4 count; Delayed diagnosis; Diagnosis; Disease stage; HIV; HIV testing

Mesh:

Year:  2016        PMID: 26542730      PMCID: PMC8666845          DOI: 10.1007/s10461-015-1241-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  15 in total

1.  Limitations of indicators of HIV case finding.

Authors:  Qiang Xia; Lucia V Torian; Colin W Shepard
Journal:  Epidemiology       Date:  2015-01       Impact factor: 4.822

2.  The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model.

Authors:  Qiang Xia; Paul Kobrak; Ellen W Wiewel; Lucia V Torian
Journal:  AIDS Care       Date:  2014-09-22

Review 3.  Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention.

Authors:  David N Burns; Victor DeGruttola; Christopher D Pilcher; Mirjam Kretzschmar; Christopher M Gordon; Elizabeth H Flanagan; Christopher Duncombe; Myron S Cohen
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-11       Impact factor: 2.205

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

5.  Results of the Expanded HIV Testing Initiative--25 jurisdictions, United States, 2007-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-06-24       Impact factor: 17.586

6.  Centers for Disease Control and Prevention Funding for HIV Testing Associated With Higher State Percentage of Persons Tested.

Authors:  Samah Hayek; Patricia M Dietz; Michelle Van Handel; Jun Zhang; Ram K Shrestha; Ya-Lin A Huang; Choi Wan; Jonathan Mermin
Journal:  J Public Health Manag Pract       Date:  2015 Nov-Dec

7.  Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach.

Authors:  Kathleen McDavid Harrison; Tebitha Kajese; H Irene Hall; Ruiguang Song
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

Review 8.  A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011.

Authors:  Catherine R Lesko; Stephen R Cole; Anne Zinski; Charles Poole; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

9.  Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2013-07-02       Impact factor: 25.391

10.  Brief report: Time from infection with the human immunodeficiency virus to diagnosis, United States.

Authors:  H Irene Hall; Ruiguang Song; Célia Landmann Szwarcwald; Timothy Green
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

View more
  14 in total

1.  Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City.

Authors:  Marya Gwadz; Charles M Cleland; David C Perlman; Holly Hagan; Samuel M Jenness; Noelle R Leonard; Amanda S Ritchie; Alexandra Kutnick
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

2.  Prevalence and correlates of HIV testing and HIV-positive status in the US: Results from the National Epidemiological Survey on Alcohol and Related Conditions III (NESARC-III).

Authors:  Carlos Blanco; Melanie M Wall; Wilson M Compton; Shoshana Kahana; Tianshu Feng; Tulshi Saha; Jennifer C Elliott; H Irene Hall; Bridget F Grant
Journal:  J Psychiatr Res       Date:  2018-08-03       Impact factor: 4.791

3.  Survival After HIV Infection Stage 3 (AIDS) Diagnosis, by Population Density Areas, United States, 2005-2010.

Authors:  Karin A Bosh; Jing Shi; Mi Chen
Journal:  Public Health Rep       Date:  2017-08-11       Impact factor: 2.792

4.  Assessing Differences in CDC-Funded HIV Testing by Urbanicity, United States, 2016.

Authors:  Deesha Patel; Nicole Taylor-Aidoo; Angèle Marandet; Janet Heitgerd; Barbara Maciak
Journal:  J Community Health       Date:  2019-02

5.  Ancillary service needs among persons new to HIV care and the relationship between needs and late presentation to care.

Authors:  Anne K Monroe; Catherine R Lesko; Geetanjali Chander; Bryan Lau; Jeanne Keruly; Heidi M Crane; K Rivet Amico; Sonia Napravnik; E Byrd Quinlivan; Michael J Mugavero
Journal:  AIDS Care       Date:  2019-02-19

6.  Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses.

Authors:  Sheila M Keating; Richard Brad Jones; Christina M Lalama; Ronald J Bosch; Deborah McMahon; Dylan Hampton; Joshua Cyktor; Joseph J Eron; John W Mellors; Michael P Busch; Rajesh T Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

7.  Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; Joseph J Eron; Stephen R Cole; David van Duin; David A Wohl; Brenna C Hogan; Keri N Althoff; Kelly A Gebo; Richard D Moore; Michael J Silverberg; Michael A Horberg; M John Gill; W Christopher Mathews; Marina B Klein; Jonathan A Colasanti; Timothy R Sterling; Angel M Mayor; Peter F Rebeiro; Kate Buchacz; Jun Li; Ni Gusti Ayu Nanditha; Jennifer E Thorne; Ank Nijhawan; Stephen A Berry
Journal:  J Infect Dis       Date:  2020-12-26       Impact factor: 5.226

8.  Case 20-2017 - A 48-Year-Old Man with Weight Loss, Confusion, Skin Lesions, and Pancytopenia.

Authors:  Shibani S Mukerji; R Gilberto Gonzalez; Rajesh T Gandhi; Stefan Kraft
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 176.079

9.  Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study.

Authors:  Itzchak Levy; Yasmin Maor; Naim Mahroum; Liraz Olmer; Anat Wieder; Vladislav Litchevski; Orna Mor; Galia Rahav
Journal:  BMJ Open       Date:  2016-11-10       Impact factor: 2.692

10.  It's a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals.

Authors:  Alexandra H Kutnick; Marya Viorst Gwadz; Charles M Cleland; Noelle R Leonard; Robert Freeman; Amanda S Ritchie; Talaya McCright-Gill; Kathy Ha; Belkis Y Martinez
Journal:  Front Public Health       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.